Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database

BACKGROUND: Non-vitamin K antagonist oral anticoagulants (NOACs) reduce the risk of stroke in patients with non-valvular atrial fibrillation (NVAF) and have better safety profile than vitamin K antagonists (VKAs). However, there is a dearth of quality, real-world, patient data on the use of these dr...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kadri, Moutaz, Ghorab, Ahmed, Joury, Jean, Farghaly, Mohamed, Awad, Nancy, Ramachandrachar, Badarinath Chickballapur, Natarajan, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101642/
https://www.ncbi.nlm.nih.gov/pubmed/33996647
http://dx.doi.org/10.4103/ajm.ajm_228_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101642/
https://www.ncbi.nlm.nih.gov/pubmed/33996647
http://dx.doi.org/10.4103/ajm.ajm_228_20

Ejemplares similares